2016 Meetings reports

There were 2 meetings this year:  Nottingham, UK (March 2016) | London, UK (October 2016) - see below...

Nottingham, UK meeting - March 2016

Overview
  1. The ups and downs of Regorafinib Treatment - Michael Sayers, Patient on Regorafinib
  2. Dosing Management on Anti-cancer Drugs - David Falconer, Former Pfizer National Lead on Sunitinib for GIST
  3. The Value of Mutational Testing - Dr Philippe Tanière, Consultant Histopathologist

1.) The ups and downs of Regorafinib Treatment - Michael Sayers, Patient on Regorafinib

2.) Dosing Management on Anti-cancer Drugs - David Falconer, Former Pfizer National Lead on Sunitinib for GIST

3.) The Value of Mutational Testing - Dr Philippe Tanière, Consultant Histopathologist

London, UK meeting - October 2016

Overview
  1. The Role of Complementary Therapies - Jeannie Dyer - Clinical Lead for Complementary Therapies, Royal Marsden

1.) The Role of Complementary Therapies - Jeannie Dyer - Clinical Lead for Complementary Therapies, Royal Marsden